Childhood acute promyelocytic leukemia: No benefit of all-trans-retinoic acid administered in a short-course schedule

Pediatric Hematology and Oncology

Volumn 17, Issue 2, 2000, Pages 155-162

  Zubizarreta, Pedro Alberto ^a,b   Rose, Adriana Beatriz ^a   Felice, María Sara ^a   Alfaro, Elizabeth ^a   Delfino, Silvia ^a   Cygler, Ana María ^a   Sackmann Muriel, Federico ^a  

^a Hospital de Pediatria SAMIC Prof Dr Juan P Garrahan   (Argentina)

^b HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

Author keywords

Acute myeloblastic leukemia; Acute promyelocytic leukemia; All trans retinoic acid; Children

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FRESH FROZEN PLASMA; IDARUBICIN; MERCAPTOPURINE; PREDNISONE; RETINOIC ACID; TIOGUANINE; VINCRISTINE;

ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BLEEDING; CANCER COMBINATION CHEMOTHERAPY; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYOPRECIPITATE; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG MEGADOSE; FEMALE; HUMAN; LEUKEMIA REMISSION; MALE; MORTALITY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; THROMBOCYTE TRANSFUSION;

EID: 0034005004     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/088800100276514     Document Type: Article

References (12)

1. Tallman MS, Kwaan HC. Reassessing the hemostatic disorder associated with acute promyelocytic leukemia. Blood. 1992;79:543-553.
2. Warrell RP, De Thé H, Yi-Wang Z, Degos L. Acute promyelocytic leukemia. N Kngl J Med. 1993;329:177-189.
3. Fenaux P, Le Deley MC, Castaigne S, et al. Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia: results of a multicenter randomized trial. European APL 91 Group. Blood. 1993;82:3241-3249.
4. Kanamaru A, Takemoto Y, Tanimoto M, et al., & The Japan Adult Leukemia Study. All-Trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Blood. 1995;85:1202-1206.
5. Avvisati G, Lo Coco F, Diverio D, et al. AIDA (all-trans-retinoic acid - idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto (GIMEMA) Pilot Study. Blood. 1996;88:1390-1398.
6. Tallman MS, Andersen JW, Schiffer CA, et al. All-fraws-retinoic acid in acute promyelocytic leukemia. N Engl J Med. 1997;337:1021-1028.
7. Sackmann-Muriel F, Zubizarreta P, Felice MS, et al. Results of treatment with an intensive induction regimen using idarubicin combination with cytarabine and etoposide in children with acute myeloblastic leukemia. Leukemia Res. 1996;20:973-981.
8. 2) in acute promyelocytic leukemia. Blood. 1993;82:3560-3563.
9. Douer D, Preston-Martin, Chang E, et al. High frequency of acute promyelocytic leukemia among Latinos with acute myeloid leukemia. Blood. 1996;87:308-313.
10. Meng-er H, Yu-chen Y, Shu-rong C, Jin-ren C, Jia-Xiang L, Long-jun G. Use of All-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood. 1988;72:567-572.
11. Burnett AK, Goldstone AH, Gray RG, Wheatley, K. All-trans-retinoic acid given concurrently with induction chemotherapy improves the outcome of APL: results of the UK MRC ATRA trial. Blood. 1997;90(suppl 1):330a (abstract 1474).
12. Frankel SR, Eardley A, Lauwers G, Weiss M, Warrell RP. The "retinoic acid syndrome" in acute promyelocytic leukemia. Ann Int Med. 1992;117:292-296.